At a glance
Read the record in context
The AOD-9604 record acknowledges published human context without claiming a complete systemic model. Its low-confidence value and 5 mg package come from distinct references. That distinction is particularly relevant when a search phrase combines dosage calculation with a desired outcome.[1]
What the research says
The cited publication summarizes six controlled human studies of AOD-9604, a modified fragment of human growth hormone. The research question focused on safety and tolerability, particularly whether the fragment reproduced unwanted metabolic effects associated with the full-length hormone. The programs included intravenous and oral administration.[2]
Investigators examined serum IGF-1, glucose tolerance, insulin-related measures, adverse events, and antibodies against AOD-9604. These endpoints test biological responses and immunogenicity, rather than merely the presence of peptide in a container. The article reports results across several designs and participant groups, including adults with obesity.[2]
The paper's pooled safety discussion should be read within those study durations and populations. It does not provide a complete human subcutaneous disposition profile for the library's modeled curve. The short systemic timing input remains a low-confidence estimate, separate from the endpoints the publication actually investigated.[2][1]
Amounts
The library uses 5 mg as an example vial size (input). It is a container total for arithmetic, not an amount selected for administration. No personal dosing range is inferred from it.[1][3]
This guide lists no human dose figure for AOD-9604, which has no human approval recorded in the PinPoint library.[1]
Explore the AOD-9604 units chartHalf-life and timing
Half of an hour sets a 30-minute step for this illustration. After three steps, 90 minutes have elapsed and the modeled quantity is one eighth of its starting value. After five, 150 minutes have elapsed and one thirty-second remains. These fractions cannot establish clinical results or fill gaps in the systemic reference. The curve is generated from one uncertain scalar, so a precise-looking endpoint does not constitute a newly measured human duration or a schedule for another amount.[1][5]
The cited half-life reference
Clinical and metabolic reference with limited systemic details; low-confidence tracking values. Library input, retrieved 2026-10-05: 0.5 hours (0.02083 days), marked low confidence in the library. It is the input behind the arithmetic below, not a measurement of anyone's levels or of how long an effect lasts.[2][1]
AOD-9604 has a 0.5-hour tracking estimate and an explicit low-confidence flag. Its source note says systemic reference details are limited. The library offers once-daily and five-times-weekly labels, but a weekly count alone leaves the spacing ambiguous: consecutive weekdays and evenly spaced entries produce different gaps. This page only calculates a ratio for an unambiguous fixed interval, preserving the distinction between a calendar label and a mathematical recurrence.[1][2]
Half-life varies with the person, formulation and study context. The source note does not establish a numerical human half-life range. This library input is low confidence and is not an established individual human value. The library lists subcutaneous for tracking. A listed route is not proof that every input was measured through that route.[1]
AOD-9604 decay table
Starting at an arbitrary 100%, each elapsed half-life divides the remaining modeled amount by two: 100 × 2 raised to the power of minus elapsed hours divided by 0.5. It describes a single contribution with no additional entries, and the percentages are not percentages of benefit or activity. Five half-lives leave 3.125%; decay never reaches zero, and this is not a detection window or washout instruction.[1][5]
| Half-lives | Hours | Days | Remaining (rounded) |
|---|---|---|---|
| 0 | 0 | 0 | 100.0% |
| 1 | 0.5 | 0.02083 | 50.0% |
| 2 | 1 | 0.04167 | 25.0% |
| 3 | 1.5 | 0.0625 | 12.5% |
| 4 | 2 | 0.08333 | 6.3% |
What the listed schedules mean mathematically
The library labels are Once daily; Five times weekly. They describe available tracking patterns, not instructions. In an equal-input model, the limiting peak accumulation ratio is 1 ÷ (1 − 2 raised to minus interval divided by half-life).[1][5]
- Once daily, if evenly spaced: 24 hours between entries; 3.553e-13% of one contribution remains at that marker; limiting accumulation ratio 1.
- Five times weekly: no unique fixed interval is specified, so no accumulation ratio is assigned.
About five half-lives here is 2.5 hours, or 0.1042 days. Under the same linear assumptions, that reaches roughly 97% of the limiting steady-state pattern, though peaks and troughs still occur. Changing amounts, missed entries, irregular spacing and absorption change the pattern; the calculation does not decide when to start, stop or change anything.[1][5]
Reconstitution
At an assumed 2 mL final volume, a 5 mg example total produces 2.5 mg/mL. An illustrative 0.1 mL then represents 0.25 mg. A calculator can express the latter as 250 micrograms without changing the mass. None of those quantities is an outcome prediction. The example does not choose an AOD-9604 administration amount or a mixing procedure; it demonstrates how explicit units prevent confusing the package total, concentration, and volume associated with an independently known amount.[3]
Tracking it in PinPoint
From a reference to a record
Built for peptide, TRT, and GLP-1 schedules. Set up your vial in seconds, log every dose, and see your modeled levels between doses. Enter vial size in mg, mcg, or IU and water volume for instant concentration and syringe units. Track vials and prefilled pens side by side.[4]
The Home curve models your levels between doses from published half-life data. Drag to scrub modeled values at any timestamp, or preview 30 days of a dose pattern. Ask PinPoint provides educational reference with sources; it never recommends a dose or a schedule change. These features record and visualize entered information, with the limits of each compound's source data still applying.
Get PinPoint on the App StoreFrequently asked questions
- Does an AOD-9604 dosage calculator for weight loss predict an outcome?
- The calculator has no outcome model. It converts entered quantities, using an example vial size only as a worked arithmetic input. The library describes incomplete systemic characterization and a low-confidence timing estimate, so the guide does not turn the search phrase into a benefit claim.[1][2]
- What does an AOD-9604 dosage calculator leave outside its calculation?
- It has no model of a desired clinical outcome and no basis for choosing the amount entered. Its inputs describe quantities, not expected results. The library's incomplete systemic characterization remains relevant even after the calculator returns a decimal volume.[1][5]
- Does published human context make every AOD-9604 timing input measured?
- The library distinguishes the existence of a publication from complete characterization of its systemic values. Its half-hour scalar remains low confidence. The guide preserves that distinction rather than presenting all three model parameters as directly measured human facts.[1][5]
- Can a peptide tracker app record AOD-9604?
- PinPoint's compound library includes AOD-9604. The app description covers logging compound, dose, site, and pain level, as well as viewing modeled levels between recorded doses. The curve uses published reference inputs and does not account for individual variation. The tracker records the schedule entered by its user; it does not choose a dose or recommend a schedule change.[1][4]
Sources
Facts and reference links were retrieved from the PinPoint application library on 5 October 2026. Links below preserve the library's citations; an example vial size (input) is arithmetic, not a sourced fact, and is not linked. Source references carried from the library have not all been independently reverified. Arithmetic examples are identified separately from clinical evidence.
- PinPoint compound library, AOD-9604Snapshot of the application library; its references and uncertainty are retained below.Retrieved 2026-10-05 · library
- Published pharmacology referenceIdentity and research summary checked against this document on 5 October 2026. Abstract and relevant methods/results or product-monograph sections.Retrieved 2026-10-05 · library-reference
- Example vial size (input)Example vial size used as an arithmetic input. It is not a sourced package fact, a clinical amount or a product endorsement.Library input, not a sourced fact
- PinPoint App Store descriptionFeature wording from the approved application description, not pricing.Retrieved 2026-10-05 · app-description
- Unit conversion and exponential-decay arithmeticC = amount / volume; remaining fraction = 2^(-elapsed / half-life). These are illustrations, not measurements.Retrieved 2026-10-05 · arithmetic
